| Within-subject Variability of Insulin Detemir in Healthy Volunteers (NCT01497535) | Novo Nordisk A/S | 2004-05-27 |
| Safety of Insulin Detemir in Children With Type 1 Diabetes (NCT00605137) | Novo Nordisk A/S | 2004-05-21 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 With Metformin in Type 2 Diabetes (NCT00624364) | Novo Nordisk A/S | 2004-05-01 |
| Metabolic Parameters 3 Months, 9 Months, and 2 Years After Bariatric Surgery (NCT00178633) | The University of Texas Health Science Center, Houston | 2004-05-01 |
| Motor Learning in Gait in Subjects With Diabetic Peripheral Neuropathy (NCT00223782) | US Department of Veterans Affairs | 2004-05-01 |
| Depression-Diabetes Mechanisms: Urban African Americans (NCT00209170) | Emory University | 2004-05-01 |
| Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism (NCT01160991) | Central Institute of Mental Health, Mannheim | 2004-05-01 |
| Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 Diabetes (NCT00592527) | Novo Nordisk A/S | 2004-04-01 |
| Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL (NCT00079638) | Kos Pharmaceuticals | 2004-04-01 |
| Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers (NCT01507337) | Novo Nordisk A/S | 2004-04-01 |
| Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia (NCT00760448) | Novo Nordisk A/S | 2004-04-01 |
| Observational Study With InnoLet® in Daily Clinical Practice (NCT01492959) | Novo Nordisk A/S | 2004-03-23 |
| Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction (NCT01492218) | Novo Nordisk A/S | 2004-03-15 |
| Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. (NCT00104572) | National Institute on Aging (NIA) | 2004-03-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes (NCT00600366) | Novo Nordisk A/S | 2004-03-01 |
| Fast Food Study: Assessment of the Effects of Fast-Food on Inflammatory Markers (NCT00233311) | National Institute on Aging (NIA) | 2004-03-01 |
| Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism (NCT00287820) | Nathan Kline Institute for Psychiatric Research | 2004-02-01 |
| Metabolic Analysis in Human Sulfur Amino Acid Deficiency (NCT00253760) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-02-01 |
| Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes (NCT01497600) | Novo Nordisk A/S | 2004-02-01 |
| Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics (NCT00157638) | Hamilton Health Sciences Corporation | 2004-02-01 |
| Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM) (NCT00234871) | Abbott | 2004-01-01 |
| Free Test Strips and Blood Glucose Control (NCT00205335) | University of Wisconsin, Madison | 2004-01-01 |
| Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes (NCT00600626) | Novo Nordisk A/S | 2004-01-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus (NCT01542060) | Novo Nordisk A/S | 2004-01-01 |
| Multi-Tracer PET Quantitation of Skeletal Muscle Insulin Resistance in Type 2 Diabetes Mellitus (NCT00222781) | University of Pittsburgh | 2004-01-01 |
| Effects of Insulin Sensitizers in Subjects With Impaired Glucose Tolerance (NCT00108615) | US Department of Veterans Affairs | 2004-01-01 |
| Comparison of Blood Pressure Medications on Metabolism (NCT00642434) | University of New Mexico | 2004-01-01 |
| Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes (NCT00568074) | Novo Nordisk A/S | 2003-12-16 |
| Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT00592969) | Novo Nordisk A/S | 2003-12-03 |
| Efficacy and Safety of Insulin Detemir in Type 1 Diabetes (NCT00595374) | Novo Nordisk A/S | 2003-12-02 |
| Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT00605020) | Novo Nordisk A/S | 2003-12-02 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes (NCT00619697) | Novo Nordisk A/S | 2003-12-01 |
| Mitochondrial Impairment in Muscle Insulin Resistance (NCT00222924) | University of Pittsburgh | 2003-12-01 |
| Paediatric Subjects - Special Survey (NCT01538576) | Novo Nordisk A/S | 2003-12-01 |
| A Study of Stress Heart Imaging in Patients With Diabetes at Risk for Coronary Disease. (NCT00162344) | Lantheus Medical Imaging | 2003-12-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes (NCT00605111) | Novo Nordisk A/S | 2003-12-01 |
| Special Survey for Patients With Type 1 or Type 2 Diabetes (NCT01538589) | Novo Nordisk A/S | 2003-12-01 |
| Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes (NCT01615978) | Novo Nordisk A/S | 2003-12-01 |
| Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy Alone (NCT00604253) | Novo Nordisk A/S | 2003-12-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Subjects (NCT01527656) | Novo Nordisk A/S | 2003-12-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects (NCT01620437) | Novo Nordisk A/S | 2003-11-29 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects (NCT01527643) | Novo Nordisk A/S | 2003-11-11 |
| Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00280046) | Novo Nordisk A/S | 2003-11-01 |
| Role of Pioglitazone in Preventing Diabetes (NCT00276497) | M.V. Hospital for Diabetes | 2003-10-01 |
| Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes (NCT00799448) | Novo Nordisk A/S | 2003-09-16 |
| Telehealth for Diabetes Self-Management (NCT00194805) | University of Washington | 2003-09-01 |
| Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 50 to Biphasic Insulin Aspart 70 in Type 2 Diabetes (NCT00612599) | Novo Nordisk A/S | 2003-09-01 |
| A Clinical Trial of Ginseng in Diabetes (NCT00781534) | Washington University School of Medicine | 2003-09-01 |
| Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers (NCT01620476) | Novo Nordisk A/S | 2003-09-01 |
| Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) (NCT00574782) | AstraZeneca | 2003-09-01 |
| Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm) (NCT00333853) | LifeScan | 2003-08-01 |
| The Effectiveness of Improving Compliance With Diabetic Preventative Services and Modifying Vascular Risk (NCT00204282) | University of Chicago | 2003-08-01 |
| Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin (NCT00569998) | Novo Nordisk A/S | 2003-08-01 |
| Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes (NCT00571935) | Novo Nordisk A/S | 2003-08-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes (NCT00617565) | Novo Nordisk A/S | 2003-07-08 |
| Improving Outcomes in Patients With Kidney Disease Due to Diabetes (NCT00381134) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-07-01 |
| Using Sugar Water to Relieve Pain in Infants (NCT00213213) | The Hospital for Sick Children | 2003-07-01 |
| ORWH:SCOR on Sex and Gender Factors Affecting Women's Incontinence (NCT00069368) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-07-01 |
| Strategies to Maintain Cardiac Risk Control After Discharge From Cardiovascular Risk Reduction Clinic (NCT00358033) | Providence VA Medical Center | 2003-07-01 |
| An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime (NCT01487421) | Novo Nordisk A/S | 2003-07-01 |
| Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes (NCT00468364) | University of Giessen | 2003-07-01 |
| Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs (NCT00791895) | Novo Nordisk A/S | 2003-06-26 |
| Retinal Blood Flow and Microthrombi in Type 1 Diabetes (NCT00406991) | Schepens Eye Research Institute | 2003-06-01 |
| Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus (NCT00057304) | Hoffmann-La Roche | 2003-06-01 |
| Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial (NCT00169832) | Laval University | 2003-06-01 |
| Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes (NCT00604656) | Novo Nordisk A/S | 2003-05-05 |
| Stop Atherosclerosis in Native Diabetics Study (NCT00147251) | Cynthia West | 2003-05-01 |
| Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes (NCT00569400) | Novo Nordisk A/S | 2003-05-01 |
| Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS) (NCT00660764) | AstraZeneca | 2003-05-01 |
| Long Term Clinical Evaluation of SLS Transtibial Sockets (NCT00167570) | The University of Texas Health Science Center at San Antonio | 2003-04-01 |
| Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes (NCT00604344) | Novo Nordisk A/S | 2003-04-01 |
| The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy Volunteers (NCT00339833) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-03-01 |
| Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes (NCT01497561) | Novo Nordisk A/S | 2003-03-01 |
| Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes (NCT00604396) | Novo Nordisk A/S | 2003-03-01 |
| Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes (NCT00283751) | Novo Nordisk A/S | 2003-03-01 |
| NovoLet® Surveillance Study on Using Human Insulin System in Indonesia (NCT01492153) | Novo Nordisk A/S | 2003-02-11 |
| Initiation of Insulin Aspart in Type 2 Diabetes (NCT00572806) | Novo Nordisk A/S | 2003-02-05 |
| Tu Salud Si Cuenta Media Campaign (NCT00788879) | The University of Texas Health Science Center, Houston | 2003-02-01 |
| In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome (NCT00302874) | Hadassah Medical Organization | 2003-02-01 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 70 in Healthy Male Subjects (NCT01527565) | Novo Nordisk A/S | 2003-01-20 |
| Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process (NCT01486914) | Novo Nordisk A/S | 2003-01-19 |
| Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library (NCT00822471) | Medstar Health Research Institute | 2003-01-01 |
| Multi-Tracer PET Quantitation of Insulin Action in Muscle (Phase 1, Phase 2, Phase 3, Phase 4) (NCT00222885) | University of Pittsburgh | 2002-12-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers (NCT01620463) | Novo Nordisk A/S | 2002-12-01 |
| Comparison of Glycemic Control Achieved With 2 Different Needles (NCT00572052) | Novo Nordisk A/S | 2002-12-01 |
| Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes (NCT00568984) | Novo Nordisk A/S | 2002-11-21 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects (NCT01527630) | Novo Nordisk A/S | 2002-11-16 |
| Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects (NCT01527552) | Novo Nordisk A/S | 2002-11-05 |
| Effects of a Multi-Faceted Psychiatric Intervention Targeted at the Complex Medically Ill: a Randomized Controlled Trial (NCT00385528) | University of Lausanne Hospitals | 2002-11-01 |
| Improving Diabetes Efforts Across Language and Literacy (IDEALL) (NCT00214474) | Agency for Healthcare Research and Quality (AHRQ) | 2002-11-01 |
| Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy (NCT00598793) | Novo Nordisk A/S | 2002-11-01 |
| Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes (NCT00567775) | Novo Nordisk A/S | 2002-10-21 |
| Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Healthy Volunteers (NCT01448070) | Novo Nordisk A/S | 2002-10-15 |
| Human Insulin NPH and Insulin Aspart in Type 1 Diabetes (NCT00597233) | Novo Nordisk A/S | 2002-10-01 |
| Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients? (NCT00704314) | Medical University of Vienna | 2002-10-01 |
| Promoting Blood Pressure Control and Cholesterol Reduction to Prevent Major Complications in Persons With Diabetes (NCT00210262) | Institute for Clinical Evaluative Sciences | 2002-10-01 |
| To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients (NCT00489229) | Universiti Sains Malaysia | 2002-10-01 |
| Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes (NCT01720303) | Novo Nordisk A/S | 2002-09-19 |
| Comparison of Two Insulin Aspart Formulations in Healthy Volunteers (NCT01698697) | Novo Nordisk A/S | 2002-09-02 |
| Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes (NCT00725036) | Novo Nordisk A/S | 2002-09-02 |